Company: STAA
Filing Date: 2025-10-16
Form Type: DEFA14A
Source: 0001193125-25-241528
Chunk: 0

Company: STAAR SURGICAL CO
Filing Date: 2025-10-16
Form: DEFA14A
Chunk 0
---
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box:

| ☐ | Preliminary Proxy Statement |

| ☐ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |

| ☐ | Definitive Proxy Statement |

| ☒ | Definitive Additional Materials |

| ☐ | Soliciting Material under § 240.14a-12 |

STAAR SURGICAL COMPANY (Name of Registrant as Specified In Its Charter) (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check the appropriate box):

| ☒ | No fee required. |

| ☐ | Fee paid previously with preliminary materials. |

| ☐ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a6(i)(1) and 0-11. |

On October 16, 2025, STAAR Surgical Company (“STAAR”) issued the following press release: STAAR Surgical Affirms that No Acquisition Proposals Have Been Received From Any Party Other Than Alcon LAKE FOREST, CA, October 16, 2025– STAAR Surgical Company (NASDAQ: STAA) (“STAAR”), the global leader in phakic IOLs with the EVO family of Implantable Collamer ®Lenses (EVO ICL ™) for vision correction, today issued the following statement: Broadwood Partners’ statements and assertions regarding interest in STAAR are misleading and distort the truth. Broadwood is misrepresenting introductory emails as offers to acquire STAAR. As previously disclosed, the communications from Party A and B were not offers and contained no information relating to valuation, timing, diligence requirements, financing capability, transaction structure or other terms. 1 Similarly, as disclosed in STAAR’s Form 8-Kfiling with the SEC on October 14, 2025, a representative of a privately-owned company (“Party C”) also emailed STAAR on April 7, 2025. Since the Form 8-Kfiling, Party C has confirmed to STAAR that “the outreach was an introductory email and was not